{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:41:23Z","timestamp":1787503283332,"version":"build-2736575974"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder associated with vascular dysfunction and increased cardiovascular risk. This study aims to investigate the dysregulation of vascular tone in PCOS, focusing on the imbalance between vasodilators (nitric oxide [NO] and apelin) and vasoconstrictors (noradrenaline and reduced prostacyclin). By examining these factors, the study seeks to elucidate their contribution to endothelial dysfunction and cardiovascular complications in PCOS patients. Forty-four patients diagnosed with PCOS according to the 2003 Rotterdam Criteria, along with 44 healthy controls, were included in the study. Ultrasound evaluations were performed on all volunteers. Serum NO, apelin, noradrenaline, and prostacyclin levels were measured using commercial enzyme-linked immunosorbent assay (ELISA) kits. Additionally, routine biochemical, hormonal, and glycated hemoglobin analyses were conducted on all samples. There was no statistically significant difference between the PCOS and control groups in terms of marital status, age, and body mass index (BMI) (p\u2009&gt;\u20090.05). Compared to the control group (83.85\u2009\u00b1\u200922.65 \u00b5mol\/L, 190.88\u2009\u00b1\u200916.44\u2009ng\/L, and 24.63\u2009\u00b1\u20094.59\u2009ng\/L, respectively), NO, apelin, and noradrenaline concentrations were significantly higher in patients with PCOS (104.35\u2009\u00b1\u200944.96 \u00b5mol\/L, 379.57\u2009\u00b1\u200940.11\u2009ng\/L, and 27.48\u2009\u00b1\u20095.36\u2009ng\/L, respectively) (p\u2009&lt;\u20090.01). In contrast, prostacyclin concentrations were significantly lower in patients with PCOS (5.85\u2009\u00b1\u20091.28\u2009ng\/L) compared to the control group (6.78\u2009\u00b1\u20091.99\u2009ng\/L) (p\u2009=\u20090.011). Additionally, a statistically significant difference was found between the PCOS and control groups in FSH, LH, testosterone, SHBG, glucose, and HDL levels (p\u2009&lt;\u20090.05). The disrupted balance between vasodilation and vasoconstriction in PCOS, driven by altered levels of NO, apelin, noradrenaline, and prostacyclin, contributes to endothelial dysfunction and increased cardiovascular risk. These molecular disturbances underline the need for targeted therapeutic strategies aimed at restoring vascular homeostasis in PCOS patients.<\/jats:p>","DOI":"10.1371\/journal.pone.0332030","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:40:12Z","timestamp":1757094012000},"page":"e0332030","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Vascular imbalance in polycystic ovary syndrome: Insights into endothelial dysfunction"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3724-0249","authenticated-orcid":true,"given":"Tu\u011fba Raika","family":"K\u0131ran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9100-2479","authenticated-orcid":true,"given":"Mehmet","family":"Erdem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engin","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyza","family":"\u0130nceo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"issue":"9","key":"pone.0332030.ref001","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/humrep\/dead156","article-title":"Recommendations from the 2023 International evidence-based guideline for the assessment and management of polycystic ovary syndrome\u2020","volume":"38","author":"HJ Teede","year":"2023","journal-title":"Hum Reprod"},{"issue":"3","key":"pone.0332030.ref002","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cen.13795","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"89","author":"HJ Teede","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"pone.0332030.ref003","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s12902-021-00890-8","article-title":"Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success","volume":"21","author":"C Ee","year":"2021","journal-title":"BMC Endocr Disord"},{"issue":"6","key":"pone.0332030.ref004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003132","article-title":"Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis","volume":"17","author":"M Dapas","year":"2020","journal-title":"PLoS Med"},{"key":"pone.0332030.ref005","doi-asserted-by":"crossref","first-page":"1361962","DOI":"10.3389\/fpubh.2024.1361962","article-title":"Association between mild depressive states in polycystic ovary syndrome and an unhealthy lifestyle","volume":"12","author":"L Li","year":"2024","journal-title":"Front Public Health"},{"key":"pone.0332030.ref006","doi-asserted-by":"crossref","first-page":"604215","DOI":"10.3389\/fendo.2021.604215","article-title":"Telomere Length Differently Associated to Obesity and Hyperandrogenism in Women With Polycystic Ovary Syndrome","volume":"12","author":"ME Velazquez","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"pone.0332030.ref007","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.2147\/DMSO.S329108","article-title":"Analysis of Endocrine and Metabolic Indexes in Non-Obese Patients with Polycystic Ovary Syndrome and Its Compare with Obese Patients","volume":"14","author":"W Shi","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"pone.0332030.ref008","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3390\/biom11091350","article-title":"Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk","volume":"11","author":"S Pandurevic","year":"2021","journal-title":"Biomolecules"},{"issue":"9","key":"pone.0332030.ref009","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3390\/diagnostics13091559","article-title":"Polycystic Ovary Syndrome: Pathophysiology and Controversies in Diagnosis","volume":"13","author":"D Fahs","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"pone.0332030.ref010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"HF Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"pone.0332030.ref011","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.3390\/nu13103425","article-title":"Effectiveness of a 6-Month Lifestyle Intervention on Diet, Physical Activity, Quality of Life, and Markers of Cardiometabolic Health in Women with PCOS and Obesity and Non-PCOS Obese Controls: One Size Fits All?","volume":"13","author":"Z Wang","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"pone.0332030.ref012","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1159\/000484107","article-title":"Impaired Arginine Metabolism Coupled to a Defective Redox Conduit Contributes to Low Plasma Nitric Oxide in Polycystic Ovary Syndrome","volume":"43","author":"MB Krishna","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"pone.0332030.ref013","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ygcen.2018.09.008","article-title":"Physiological relevance of nitric oxide in ovarian functions: An overview","volume":"279","author":"P Nath","year":"2019","journal-title":"Gen Comp Endocrinol"},{"issue":"3","key":"pone.0332030.ref014","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3390\/ijerph18030980","article-title":"Novel Insights on the Role of Nitric Oxide in the Ovary: A Review of the Literature","volume":"18","author":"MC Budani","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"pone.0332030.ref015","doi-asserted-by":"crossref","first-page":"5570331","DOI":"10.1155\/2021\/5570331","article-title":"Effect of Omega-3 or Omega-6 Dietary Supplementation on Testicular Steroidogenesis, Adipokine Network, Cytokines, and Oxidative Stress in Adult Male Rats","volume":"2021","author":"A Moustafa","year":"2021","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"pone.0332030.ref016","first-page":"737","article-title":"Search for an endogenous ligand of the orphan G protein-coupled receptor--discovery of apelin, a novel biologically active peptide","volume":"58","author":"K Tatemoto","year":"2000","journal-title":"Nihon Rinsho"},{"issue":"5","key":"pone.0332030.ref017","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/jch.12075","article-title":"Masked hypertension and atherogenesis: the impact of apelin and relaxin plasma levels","volume":"15","author":"DP Papadopoulos","year":"2013","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"12","key":"pone.0332030.ref018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083051","article-title":"Apelin-13 inhibits large-conductance Ca2+-activated K+ channels in cerebral artery smooth muscle cells via a PI3-kinase dependent mechanism","volume":"8","author":"A Modgil","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"pone.0332030.ref019","article-title":"Increased cyclooxygenase-2-derived prostanoids contributes to the hyperreactivity to noradrenaline in mesenteric resistance arteries from offspring of diabetic rats","volume":"7","author":"FE Ramos-Alves","year":"2012","journal-title":"PLoS One"},{"issue":"16","key":"pone.0332030.ref020","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030353","article-title":"Progranulin Maintains Blood Pressure and Vascular Tone Dependent on EphrinA2 and Sortilin1 Receptors and Endothelial Nitric Oxide Synthase Activation","volume":"12","author":"A Bruder-Nascimento","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"pone.0332030.ref021","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/ijms23031042","article-title":"Impairment of Anti-Aggregatory Responses to Nitric Oxide and Prostacyclin: Mechanisms and Clinical Implications in Cardiovascular Disease","volume":"23","author":"YY Chirkov","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"pone.0332030.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33549\/physiolres.935206","article-title":"Periovarian Adipose Tissue - an Impact on Ovarian Functions","volume":"73","author":"W Szyrzisko","year":"2024","journal-title":"Physiol Res"},{"issue":"7","key":"pone.0332030.ref023","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/humrep\/16.7.1334","article-title":"Plasma concentrations of nitrate during the menstrual cycle, ovarian stimulation and ovarian hyperstimulation syndrome","volume":"16","author":"E Ekerhovd","year":"2001","journal-title":"Hum Reprod"},{"issue":"15","key":"pone.0332030.ref024","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.3390\/ijms20153778","article-title":"Ovarian Expression of Adipokines in Polycystic Ovary Syndrome: A Role for Chemerin, Omentin, and Apelin in Follicular Growth Arrest and Ovulatory Dysfunction?","volume":"20","author":"A Bongrani","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6","key":"pone.0332030.ref025","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/cen.12003","article-title":"The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?","volume":"77","author":"A Lansdown","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"pone.0332030.ref026","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/biomedicines9010057","article-title":"Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?","volume":"9","author":"K Kurakula","year":"2021","journal-title":"Biomedicines"},{"issue":"10","key":"pone.0332030.ref027","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"G Paradisi","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"pone.0332030.ref028","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mcna.2022.10.004","article-title":"Polycystic Ovarian Syndrome","volume":"107","author":"S Shrivastava","year":"2023","journal-title":"Med Clin North Am"},{"issue":"1","key":"pone.0332030.ref029","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41598-024-84338-8","article-title":"Evaluation of ovarian stiffness and its biological mechanism using shear wave elastography in polycystic ovary syndrome","volume":"15","author":"Y He","year":"2025","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0332030.ref030","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses","volume":"41","author":"F Faul","year":"2009","journal-title":"Behav Res Methods"},{"issue":"2","key":"pone.0332030.ref031","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jcem.87.2.8199","article-title":"Altered vascular function in young women with polycystic ovary syndrome","volume":"87","author":"CJG Kelly","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"pone.0332030.ref032","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"AE Joham","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"pone.0332030.ref033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-015-0615-4","article-title":"Emerging Role of Nitric Oxide and Heat Shock Proteins in Insulin Resistance","volume":"18","author":"MN Molina","year":"2016","journal-title":"Curr Hypertens Rep"},{"issue":"9","key":"pone.0332030.ref034","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1177\/0300060519864493","article-title":"Nitric oxide (NO) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis","volume":"47","author":"C Meng","year":"2019","journal-title":"J Int Med Res"},{"issue":"7","key":"pone.0332030.ref035","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/09513590.2011.569607","article-title":"Evaluation of endothelial dysfunction, lipid metabolism in women with polycystic ovary syndrome: relationship of paraoxonase 1 activity, malondialdehyde levels, low-density lipoprotein subfractions, and endothelial dysfunction","volume":"28","author":"F Bayram","year":"2012","journal-title":"Gynecol Endocrinol"},{"issue":"7","key":"pone.0332030.ref036","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF03345614","article-title":"The relationship of the interleukin-6 -174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients","volume":"31","author":"M Erdogan","year":"2008","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"pone.0332030.ref037","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0412.2011.01337.x","article-title":"Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome","volume":"91","author":"G Baskol","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"6","key":"pone.0332030.ref038","article-title":"Serum Heat Shock Protein 70 Concentration in Relation to Polycystic Ovary Syndrome in a Non-Obese Chinese Population","volume":"8","author":"H Gao","year":"2013","journal-title":"PLoS One"},{"key":"pone.0332030.ref039","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.12659\/MSM.894926","article-title":"Evaluation of Apelin and Insulin Resistance in Patients with PCOS and Therapeutic Effect of Drospirenone-Ethinylestradiol Plus Metformin","volume":"21","author":"X Sun","year":"2015","journal-title":"Med Sci Monit"},{"key":"pone.0332030.ref040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejogrb.2024.03.034","article-title":"Relationship between serum apelin, visfatin levels, and body composition in Polycystic Ovary Syndrome patients","volume":"297","author":"D Kuai","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"pone.0332030.ref041","doi-asserted-by":"crossref","first-page":"536896","DOI":"10.1155\/2014\/536896","article-title":"Does polycystic ovary syndrome itself have additional effect on apelin levels?","volume":"2014","author":"D Benk Silfeler","year":"2014","journal-title":"Obstet Gynecol Int"},{"issue":"13","key":"pone.0332030.ref042","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.steroids.2012.08.005","article-title":"Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-\u03b1 levels in non-obese women with polycystic ovary syndrome","volume":"77","author":"YS Choi","year":"2012","journal-title":"Steroids"},{"key":"pone.0332030.ref043","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejogrb.2014.02.022","article-title":"Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome","volume":"176","author":"S\u00d6 Altinkaya","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"pone.0332030.ref044","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/cen.12152","article-title":"Neutrophil leucocytosis and polycystic ovarian syndrome--could elevated noradrenaline levels due to obstructive sleep apnoea be a contributing mechanism?","volume":"79","author":"A Morton","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"pone.0332030.ref045","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3389\/fphys.2019.01309","article-title":"In Adult Rats With Polycystic Ovarian Syndrome, Unilateral or Bilateral Vagotomy Modifies the Noradrenergic Concentration in the Ovaries and the Celiac Superior Mesenteric Ganglia in Different Ways","volume":"10","author":"R Linares","year":"2019","journal-title":"Front Physiol"},{"issue":"6","key":"pone.0332030.ref046","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3109\/09513590.2015.1130808","article-title":"Follicular fluid norepinephrine and dopamine concentrations are higher in polycystic ovary syndrome","volume":"32","author":"N Musal\u0131","year":"2016","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"pone.0332030.ref047","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s12020-023-03404-9","article-title":"Plasma-free metanephrines, nerve growth factor, and renalase significance in patients with PCOS","volume":"81","author":"R Robeva","year":"2023","journal-title":"Endocrine"},{"issue":"2","key":"pone.0332030.ref048","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1096\/fj.05-4395fje","article-title":"Role of nuclear receptor signaling in platelets: antithrombotic effects of PPARbeta","volume":"20","author":"FY Ali","year":"2006","journal-title":"FASEB J"},{"issue":"2","key":"pone.0332030.ref049","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1096\/fj.08-106591","article-title":"Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone","volume":"23","author":"C Bolego","year":"2009","journal-title":"FASEB J"},{"issue":"12","key":"pone.0332030.ref050","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1210\/en.2011-1424","article-title":"Endothelial dysfunction in a rat model of PCOS: evidence of increased vasoconstrictor prostanoid activity","volume":"152","author":"J Keller","year":"2011","journal-title":"Endocrinology"},{"issue":"2","key":"pone.0332030.ref051","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/HYPERTENSIONAHA.114.03283","article-title":"Elevated testosterone levels during rat pregnancy cause hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in uterine arteries","volume":"64","author":"V Chinnathambi","year":"2014","journal-title":"Hypertension"},{"issue":"7","key":"pone.0332030.ref052","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.3390\/ijms22073789","article-title":"Chronic Low Grade Inflammation in Pathogenesis of PCOS","volume":"22","author":"E Rudnicka","year":"2021","journal-title":"Int J Mol Sci"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:40:46Z","timestamp":1757094046000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0332030"}},"subtitle":[],"editor":[{"given":"Mukhtiar","family":"Baig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":52,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0332030","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}